The Venture Codex Logo

The Venture Codex

Cumulus Oncology

61 Dublin Street, Edinburgh, Midlothian, EH3 6NL, United Kingdom

Overview

Develops anti-cancer therapies targeting key pathways for better outcomes.

Founded

2017

Deals · 12mo

0

Links

WebsiteLinkedIn

Stage focus

—

Geographic focus

United Kingdom

Sector focus

Biotechnology
Health Care
Oncology
Pharmaceutical

Investment portfolio

1rounds
NAMEDATESIZE
Nodus Oncology
Feb 2023Led
$3 MOther Equity
Nodus Oncology
Feb 2023Led
$3 MOther Equity
1
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Cumulus Oncology: 1 funding rounds are recorded in the selected participation categories.All available history.
Cumulus Oncology: 1 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Other Equity10

Monthly Deal Activity

Cumulus Oncology: 1 deals are recorded across 45 months.All available history.
Cumulus Oncology: 1 deals are recorded across 45 months. All available history
MonthDeals
Feb '231
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Cumulus Oncology: Health & Life Sciences is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Cumulus Oncology: Health & Life Sciences is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Health & Life Sciences1

Deal Size Distribution

Cumulus Oncology: 1 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Cumulus Oncology: 1 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M1
$5M-$10M0
$10M-$25M0
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

Cumulus Oncology: Europe has the largest recorded deal count among the displayed regions (1 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

Cumulus Oncology: Europe has the largest recorded deal count among the displayed regions (1 deals). All available history
RegionDeals
Europe1
Cumulus Oncology: 1 co-investor is shown, with KHAN Technology Transfer Fund I sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Cumulus Oncology: 1 co-investor is shown, with KHAN Technology Transfer Fund I sharing 1 recorded deals. All available history
Co-investorShared deals
KHAN Technology Transfer Fund I1

Investment Strategy

Cumulus Oncology: Led accounts for 100% and participating for 0% of round participation.All available history.
Cumulus Oncology: Led accounts for 100% and participating for 0% of round participation. All available history
CategoryDeals (count)Share (%)
Led1100%
Participating00%
Cumulus Oncology: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
Cumulus Oncology: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

Clare Wareing

Founder and CEO

Dr Diane Seimetz

Non-Executive Director

Dr Sally Waterman

Non Executive Director

Nicola Broughton

Chief Business Officer